Dangprasirt P, Pongwai S
Faculty of Pharmacy, Rangsit University Patumtani, Thailand.
Drug Dev Ind Pharm. 1998 Oct;24(10):947-53. doi: 10.3109/03639049809097274.
Controlled-release, solid dispersions of diclofenac sodium (DS) were prepared by freeze-drying technique, using ethylcellulose (EC) and chitosan (CS) as single and combined carriers. Factorial design was applied as an experimental design to study the main and interactive effects of EC and CS on drug dissolution from the controlled release solid dispersion. All DS solid dispersions showed slower drug dissolution than did DS powder. The equations of dissolution parameters as functions of EC and CS contents were established through multiple regression. The contour plots of the established equations were constructed. The 10:(2.4 + 0.05) DS:(EC + CS) solid dispersion was prepared and developed into a capsule dosage from, using lactose as diluent. The effect on capsule dissolution of a disintegrant, sodium starch glycolate (Explotab), in concentrations of 2%, 5%, and 8% was studied. The solid-dispersion capsule containing 5% Explotab was found to provide the most similar dissolution profile to the one obtained with the 10:(2.4 + 0.05) DS:(EC + CS) solid-dispersion powder. The dissolutions of the 10:(2.4 + 0.05) solid-dispersion powder and capsules were closer to a first-order model than to a zero-order or diffusion control model.
采用冷冻干燥技术,以乙基纤维素(EC)和壳聚糖(CS)作为单一载体及复合载体,制备了双氯芬酸钠(DS)控释固体分散体。采用析因设计作为实验设计,研究EC和CS对控释固体分散体中药物溶出的主要和交互作用。所有DS固体分散体的药物溶出均比DS粉末慢。通过多元回归建立了溶出参数与EC和CS含量的函数方程。构建了所建立方程的等高线图。以乳糖为稀释剂,制备了10:(2.4 + 0.05) DS:(EC + CS)固体分散体,并将其开发成胶囊剂型。研究了浓度为2%、5%和8%的崩解剂羟丙基淀粉钠(Explotab)对胶囊溶出的影响。发现含有5% Explotab的固体分散体胶囊的溶出曲线与10:(2.4 + 0.05) DS:(EC + CS)固体分散体粉末的溶出曲线最为相似。10:(2.4 + 0.05)固体分散体粉末和胶囊的溶出更符合一级模型,而非零级或扩散控制模型。